Figure 7.
Figure 7. CD4+CD25+ T cells protect CD8+ T cells from AICD. (A) Apoptosis of anti-CD3–stimulated CD8+ T cells was diminished in the presence of CD4+CD25+ T cells, compared with the presence of CD4+CD25– T cells. Anti-CD3 stimulation resulted in a 57% increase of apoptosis over baseline, stimulation with PMA/ionomycin yielded similar results (not shown). (B-C) Apoptosis of HCV peptide-stimulated T-cell lines of an HCV-recovered (Ch1605) and a persistently HCV-infected chimpanzee (Ch6412) was diminished in the presence of CD4+CD25+ TRegs, compared with the presence of CD4+CD25– T cells. The results are representative for 6 experiments, using HCVcore41-, HCV-NS31444-, and HCV-NS31357-stimulated T-cell lines of recovered and persistently infected chimpanzees.

CD4+CD25+ T cells protect CD8+ T cells from AICD. (A) Apoptosis of anti-CD3–stimulated CD8+ T cells was diminished in the presence of CD4+CD25+ T cells, compared with the presence of CD4+CD25 T cells. Anti-CD3 stimulation resulted in a 57% increase of apoptosis over baseline, stimulation with PMA/ionomycin yielded similar results (not shown). (B-C) Apoptosis of HCV peptide-stimulated T-cell lines of an HCV-recovered (Ch1605) and a persistently HCV-infected chimpanzee (Ch6412) was diminished in the presence of CD4+CD25+ TRegs, compared with the presence of CD4+CD25 T cells. The results are representative for 6 experiments, using HCVcore41-, HCV-NS31444-, and HCV-NS31357-stimulated T-cell lines of recovered and persistently infected chimpanzees.

Close Modal

or Create an Account

Close Modal
Close Modal